Is antithrombotic prophylaxis required in cancer patients with central venous catheters? Yes for special patient groups

J Thromb Haemost. 2006 Jan;4(1):10-3. doi: 10.1111/j.1538-7836.2005.01735.x.
No abstract available

MeSH terms

  • Catheterization, Central Venous / adverse effects*
  • Clinical Trials as Topic
  • Fibrinolytic Agents / adverse effects*
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Neoplasms / complications*
  • Practice Guidelines as Topic
  • Premedication / adverse effects*
  • Thrombosis / etiology
  • Thrombosis / prevention & control*
  • Treatment Outcome

Substances

  • Fibrinolytic Agents